Market Trends to Watch for Health Systems and Their Specialty Pharmacies
This article was published in MedCity News on November 18, 2024. The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for…
RA Outcomes 2023
RA is an autoimmune and inflammatory disease where the immune system attacks healthy cells, causing inflammation and painful swelling in the affected parts of the body.
MS Outcomes 2023
MS is a chronic, autoimmune disease of the central nervous system, affecting the communication between the brain and other parts of the body
RA Outcomes 2022
RA is an autoimmune and inflammatory disease where the immune system attacks healthy cells, causing inflammation and painful swelling in the affected parts of the body.
MS Outcomes 2022
MS is a chronic, autoimmune disease of the central nervous system, affecting the communication between the brain and other parts of the body
Walgreens Boots Alliance ‘Specialty Pharmacy Accelerator’ Says It Helps Lower Out-of-Pocket Costs, Improve Outcomes for People with MS
This article was published in Managed Healthcare Executive on Sep 20, 2023. Learn how Shields Health Solutions is improving outcomes for people living with complex, chronic conditions, such as Multiple…
Clinical Outcomes in Rheumatoid Arthritis Patients Enrolled in an Integrated Specialty Pharmacy Care Model
The poster highlights successful therapy responses in Rheumatoid arthritis patients within an integrated HSSP program, employing measures like RAPID3 and absenteeism data to improve disease management and quality of life.…
Impact of an Embedded Rheumatology Pharmacist
This poster examines how adding an ambulatory clinical pharmacist to a rheumatology practice improves provider satisfaction, enhances patient care through timely medication approvals, and may positively impact treatment initiation and…
Multisite Health-Systems Specialty Pharmacy Study Evaluates Adherence to Self-Administered Biologic Disease-Modifying Antirheumatic Drugs
High adherence to treatment is a key first step toward better patient outcomes, including sustained disease control or remission. Adherence to self-administered biologic disease-modifying antirheumatic drugs (bDMARDs) is a key…
- 1
- 2